S. Murray Yule
- Molecular Biology
- Pathology and Forensic Medicine top 5%
- Oncology top 10%
- Public Health, Environmental and Occupational Health top 10%
- Pediatrics, Perinatology and Child Health top 10%
- Co-authors
- Alan V. BoddyL PriceAndrew D.J. PearsonJeffrey R. IdleRuth WyllieMichael ColeM TassoEJ Estlin
- Topics
- Acute Lymphoblastic Leukemia research (8 papers)Chemotherapy-induced organ toxicity mitigation (7 papers)Childhood Cancer Survivors' Quality of Life (5 papers)
- Partner nations
- United KingdomNetherlandsBelgium
In The Last Decade
S. Murray Yule
21 papers receiving 768 citations
Peers
Comparison fields: 5 of 86
- Molecular Biology 266
- Pathology and Forensic Medicine 254
- Oncology 233
- Public Health, Environmental and Occupational Health 178
- Pediatrics, Perinatology and Child Health 133
Countries citing papers authored by S. Murray Yule
This map shows the geographic impact of S. Murray Yule's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Murray Yule with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Murray Yule more than expected).
Fields of papers citing papers by S. Murray Yule
This network shows the impact of papers produced by S. Murray Yule. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Murray Yule. The network helps show where S. Murray Yule may publish in the future.
Co-authorship network of co-authors of S. Murray Yule
This figure shows the co-authorship network connecting the top 25 collaborators of S. Murray Yule. A scholar is included among the top collaborators of S. Murray Yule based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Murray Yule. S. Murray Yule is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 52 | |
| 2 | 7 | |
| 3 | 47 | |
| 4 | 5 | |
| 5 | 31 | |
| 6 | 8 | |
| 7 | 59 | |
| 8 | 26 | |
| 9 | 163 | |
| 10 | 15 | |
| 11 | 27 | |
| 12 | Cyclophosphamide and ifosfamide metabolites in the cerebrospinal fluid of children. | 42 |
| 13 | 18 | |
| 14 | 27 | |
| 15 | 70 | |
| 16 | 9 | |
| 17 | 35 | |
| 18 | Cyclophosphamide metabolism in children. | 51 |
| 19 | 4 | |
| 20 | Pharmacokinetics and metabolism of ifosfamide administered as a continuous infusion in children. | 49 |
About S. Murray Yule
S. Murray Yule is a scholar working on Pharmacology, Hematology and Pathology and Forensic Medicine, having authored 21 papers that have together received 784 indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (8 papers), Chemotherapy-induced organ toxicity mitigation (7 papers) and Childhood Cancer Survivors' Quality of Life (5 papers). The work is most often cited by research in Pharmacology (126 citations), Pathology and Forensic Medicine (254 citations) and Hematology (117 citations). S. Murray Yule has collaborated with scholars based in United Kingdom, Netherlands and Belgium. Frequent co-authors include Alan V. Boddy, L Price, Andrew D.J. Pearson, Jeffrey R. Idle, Ruth Wyllie, Michael Cole, M Tasso, EJ Estlin, A D Pearson and Alex D. McMahon. Their work appears in journals such as Journal of Clinical Oncology, Clinical Cancer Research and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.